Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical NK Cell Infusion in Refractory or Relapsed Malignant Melanoma
NCT00846833Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical NK cell in Malignant Melanoma (MM), sponsored by Seoul National University Hospital. Started Feb 2009; status: completed.
02
Drugs
haploidentical NK cell
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00846833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846833.